Evidence map›Paper›PMID 40452719›Full record

ArticleCureus2025

Newly Diagnosed Systemic Lupus Erythematosus in a 14-Year-Old Female.

Hannah Nix, Erin S Reid, Kate E Gargiula, Ashley George, Amanda Gold

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hannah NixInternal Medicine, Alabama College of Osteopathic Medicine, Dothan, USA.
Erin S ReidInternal Medicine, Alabama College of Osteopathic Medicine, Dothan, USA.
Kate E GargiulaInternal Medicine, Alabama College of Osteopathic Medicine, Dothan, USA.
Ashley GeorgeInternal Medicine, Alabama College of Osteopathic Medicine, Dothan, USA.
Amanda GoldPediatrics, Gulf Shores Pediatrics, Gulf Shores, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juvenile-onset systemic lupus erythematosus (jSLE) is a rare, life-threatening autoimmune disease that can be seen in the pediatric population. jSLE patients are more prone to highly aggressive forms of this condition when compared to adult-onset counterparts. This makes early recognition and adequate immunosuppressive therapies key in preventing end-organ damage. SLE is classically managed clinically with antimalarials and glucocorticoids, but injectable biologic therapies are slowly becoming part of mainstream care. Our case report highlights a 14-year-old female who presents with a persistent facial rash, headaches, and weight loss following treatment for Influenza B.

Indexed as

antinuclear antibodiesautoimmune disordersbiologic treatmentjslemalar rash

Identifiers

PMID40452719
PMCPMC12126081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.